Literature DB >> 9406583

A microsatellite within the MUC1 locus at 1q21 is altered in the neoplastic cells of breast cancer patients.

M R Waltz1, S M Pandelidis, W Pratt, D Barnes, D M Swallow, S J Gendler, E P Cohen.   

Abstract

Paired DNA samples from the neoplastic and nonneoplastic cells of 118 patients with the sporadic, nonfamilial form of breast cancer were analyzed for evidence of genetic alteration at a polymorphic microsatellite mapped to intron 6 within the MUC1 gene at 1q21. Two other microsatellite loci, D1S104 and APO-A2, which also map to 1q21, were analyzed as well. The frequency of alteration at the microsatellite within the MUC1 locus was significantly higher than D1S104 or APO-A2 (P < 0.001). Analysis by Southern blotting of the VNTR region of the MUC1 gene revealed an amplification of one allele in 34 of 54 informative cases (63%). There was no significant association between these alterations and alterations of the microsatellite within the same locus, suggesting independent mechanisms were responsible for the genetic changes. Microsatellite loci D17S579 at 17q21, the site of the BRCA1 gene, and D18S34 at 18q21-qter, the deleted in colorectal cancer locus, were also analyzed by PCR. Alterations at D17S579 and D18S34 were detected in 18.8% and 6.2% of patients, respectively (P < 0.001, and P < 0.1 relative to the frequency of alteration at D1S104 or APO-A2). A previously described polymorphism of hMSH2 was altered in 16.4% of cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9406583     DOI: 10.1016/s0165-4608(97)00015-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance.

Authors:  Deepak Parashar; Anjali Geethadevi; Sonam Mittal; Lindsey A McAlarnen; Jasmine George; Ishaque P Kadamberi; Prachi Gupta; Denise S Uyar; Elizabeth E Hopp; Holli Drendel; Erin A Bishop; William H Bradley; Kathleen M Bone; Janet S Rader; Sunila Pradeep; Pradeep Chaluvally-Raghavan
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

2.  Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.

Authors:  Kristina A Williams; Kathryn L Terry; Shelley S Tworoger; Allison F Vitonis; Linda J Titus; Daniel W Cramer
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.